JP2021507912A5 - - Google Patents

Download PDF

Info

Publication number
JP2021507912A5
JP2021507912A5 JP2020534474A JP2020534474A JP2021507912A5 JP 2021507912 A5 JP2021507912 A5 JP 2021507912A5 JP 2020534474 A JP2020534474 A JP 2020534474A JP 2020534474 A JP2020534474 A JP 2020534474A JP 2021507912 A5 JP2021507912 A5 JP 2021507912A5
Authority
JP
Japan
Prior art keywords
isopropyl
pyridine
pyrrolo
triazolo
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020534474A
Other languages
English (en)
Japanese (ja)
Other versions
JP7304352B2 (ja
JP2021507912A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/066107 external-priority patent/WO2019126082A1/en
Publication of JP2021507912A publication Critical patent/JP2021507912A/ja
Publication of JP2021507912A5 publication Critical patent/JP2021507912A5/ja
Application granted granted Critical
Publication of JP7304352B2 publication Critical patent/JP7304352B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020534474A 2017-12-19 2018-12-18 6-アザインドール化合物 Active JP7304352B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762607507P 2017-12-19 2017-12-19
US62/607,507 2017-12-19
PCT/US2018/066107 WO2019126082A1 (en) 2017-12-19 2018-12-18 6-azaindole compounds

Publications (3)

Publication Number Publication Date
JP2021507912A JP2021507912A (ja) 2021-02-25
JP2021507912A5 true JP2021507912A5 (enExample) 2022-01-04
JP7304352B2 JP7304352B2 (ja) 2023-07-06

Family

ID=65003572

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020534474A Active JP7304352B2 (ja) 2017-12-19 2018-12-18 6-アザインドール化合物

Country Status (14)

Country Link
US (2) US11427580B2 (enExample)
EP (1) EP3728253B1 (enExample)
JP (1) JP7304352B2 (enExample)
KR (1) KR102742181B1 (enExample)
CN (1) CN111699185B (enExample)
AU (1) AU2018390543A1 (enExample)
BR (1) BR112020011788A2 (enExample)
CA (1) CA3085761A1 (enExample)
EA (1) EA202091508A1 (enExample)
ES (1) ES2977657T3 (enExample)
IL (1) IL275365A (enExample)
MX (1) MX2020005873A (enExample)
SG (1) SG11202005704RA (enExample)
WO (1) WO2019126082A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
ES2904773T3 (es) * 2017-12-20 2022-04-06 Bristol Myers Squibb Co Compuestos de diazaindol
KR102730859B1 (ko) * 2017-12-20 2024-11-15 브리스톨-마이어스 스큅 컴퍼니 아릴 및 헤테로아릴 치환된 인돌 화합물
BR112020011984A2 (pt) * 2017-12-20 2020-11-17 Bristol-Myers Squibb Company compostos de amino indol úteis como inibidores de tlr
JP7328977B2 (ja) 2018-02-12 2023-08-17 エフ. ホフマン-ラ ロシュ アーゲー ウイルス感染の処置および予防のための新規のスルホン化合物および誘導体
PE20210131A1 (es) 2018-06-05 2021-01-19 Hoffmann La Roche COMPUESTOS TETRAHIDRO-1H-PIRAZINO[2,1-a]ISOINDOLILQUINOLINA PARA EL TRATAMIENTO DE ENFERMEDADES AUTOINMUNES
EP3807270B1 (en) 2018-06-12 2023-09-13 F. Hoffmann-La Roche AG Novel heteroaryl heterocyclyl compounds for the treatment of autoimmune disease
EP3826724B1 (en) 2018-07-23 2022-10-05 F. Hoffmann-La Roche AG Novel piperazine compounds for the treatment of autoimmune disease
WO2020048583A1 (en) 2018-09-04 2020-03-12 F. Hoffmann-La Roche Ag Benzothiazole compounds for the treatment of autoimmune diseases
EP3847173B1 (en) 2018-09-06 2023-04-12 F. Hoffmann-La Roche AG Novel pyrazolopyridine compounds for the treatment of autoimmune disease
US11548884B2 (en) 2018-09-06 2023-01-10 Hoffmann-La Roche Inc. Cyclic amidine compounds for the treatment of autoimmune disease
GB201913752D0 (en) 2019-09-24 2019-11-06 Syngenta Crop Protection Ag Herbicidal compounds
GB201914277D0 (en) 2019-10-03 2019-11-20 Syngenta Crop Protection Ag Herbicidal compounds
EP4051387B1 (en) 2019-10-31 2025-02-19 F. Hoffmann-La Roche AG Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune disease
US12486273B2 (en) 2019-11-19 2025-12-02 Hoffmann-La Roche Inc. Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune disease
WO2021099406A1 (en) 2019-11-20 2021-05-27 F. Hoffmann-La Roche Ag Spiro(isobenzofuranazetidine) compounds for the treatment of autoimmune disease
GB201917898D0 (en) 2019-12-06 2020-01-22 Syngenta Crop Protection Ag Herbicidal compounds
JP7462772B2 (ja) 2020-08-13 2024-04-05 エルジー エナジー ソリューション リミテッド 改善された電極リード接続構造を有するバッテリーモジュール、それを含むバッテリーパック及び自動車
IL300727A (en) 2020-08-19 2023-04-01 Bristol Myers Squibb Co Imidazo[1,2-a]pyridine and [1,2,4]triazolo[1,5-a]pyridine derivatives as tlr9 inhibitors for the treatment of fibrosis
CA3189816A1 (en) * 2020-08-19 2022-02-24 Chunjian Liu Substituted heteroaryl compounds useful as inhibitors of tlr9
AU2021328577A1 (en) * 2020-08-19 2023-03-23 Bristol-Myers Squibb Company 1H-pyrrolo[3,2-c]pyridine and 1H-pyrrolo[2,3-c]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis
JP2023538619A (ja) 2020-08-19 2023-09-08 ブリストル-マイヤーズ スクイブ カンパニー 線維症の処置のためのtlr9阻害剤としての1h-ベンゾ[d]イミダゾール誘導体
JP7588224B2 (ja) 2020-10-05 2024-11-21 エンライブン インコーポレイテッド Bcr-ablチロシンキナーゼの阻害のための5-及び6-アザインドール化合物
CN116783202A (zh) * 2021-02-09 2023-09-19 吉利德科学公司 噻吩并吡咯化合物
TWI861488B (zh) 2021-04-16 2024-11-11 美商基利科學股份有限公司 噻吩并吡咯化合物
KR20240056747A (ko) 2021-09-10 2024-04-30 길리애드 사이언시즈, 인코포레이티드 티에노피롤 화합물
CN114591339B (zh) * 2022-05-10 2022-08-02 上海维申医药有限公司 一类Toll样受体抑制剂及其制备和应用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468757A (en) * 1994-01-31 1995-11-21 Eli Lilly And Company 6-azaindole thromboxane synthase inhibitors
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
JP2002532479A (ja) 1998-12-18 2002-10-02 アクシス・ファーマシューティカルズ・インコーポレイテッド プロテアーゼインヒビター
WO2000038683A1 (en) * 1998-12-23 2000-07-06 Du Pont Pharmaceuticals Company THROMBIN OR FACTOR Xa INHIBITORS
GEP20053530B (en) 1999-10-19 2005-05-25 Merck & Co Inc Tyrosine Kinase Inhibitors, Pharmaceutical Compositions Containing Them and Use Thereof
ES2262996T3 (es) 2002-01-07 2006-12-01 Eisai Co., Ltd. Deazapurinas y sus usos.
BRPI0411514A (pt) 2003-06-20 2006-08-01 Coley Pharm Gmbh antagonistas de receptor toll-like de molécula pequena
US20060235037A1 (en) 2005-04-15 2006-10-19 Purandare Ashok V Heterocyclic inhibitors of protein arginine methyl transferases
EP2010187A4 (en) 2006-04-04 2010-11-17 Myriad Genetics Inc CONNECTIONS FOR DISEASES AND FUNCTIONAL DISORDERS
DE102006033109A1 (de) 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
US8027888B2 (en) 2006-08-31 2011-09-27 Experian Interactive Innovation Center, Llc Online credit card prescreen systems and methods
DE602007012133D1 (de) 2006-12-01 2011-03-03 Andrew Burritt Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
WO2008152471A1 (en) 2007-06-12 2008-12-18 Coley Pharmaceutical Group, Inc. Quinazoline derivative useful as toll-like receptor antagonist
WO2009030996A1 (en) 2007-09-05 2009-03-12 Coley Pharmaceutical Group, Inc. Triazole compounds as toll-like receptor (tlr) agonists
EP2205085A1 (en) 2007-09-25 2010-07-14 Merck Sharp & Dohme Corp. 2-aryl or heteroaryl indole derivatives
FR2930249B1 (fr) 2008-04-21 2010-05-14 Sanofi Aventis Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique.
WO2010036905A1 (en) 2008-09-26 2010-04-01 Eisai R & D Management Co., Ltd. Benzoxazole compounds and methods of use
US20110183975A1 (en) 2008-10-07 2011-07-28 Yasuhiro Goto Novel 6-azaindole aminopyrimidine derivatives having nik inhibitory activity
US8785489B2 (en) 2008-10-17 2014-07-22 Boehringer Ingelheim International Gmbh Heteroaryl substituted indole compounds useful as MMP-13 inhibitors
TWI462920B (zh) 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
NO2453895T3 (enExample) 2009-07-16 2018-10-20
CA2771026A1 (en) 2009-09-24 2011-03-31 F. Hoffmann-La Roche Ag Indole derivatives as crac modulators
AU2010310449A1 (en) 2009-10-22 2012-05-03 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
WO2012054862A2 (en) 2010-10-21 2012-04-26 The Brigham And Women's Hospital, Inc. Agents, compositions, and methods for treating pruritis and related skin conditions
US9718796B2 (en) 2011-01-12 2017-08-01 Ventirx Pharmaceuticals, Inc. Substituted benzoazepines as toll-like receptor modulators
BR112013017947A2 (pt) 2011-01-12 2018-12-18 Array Biopharma Inc benzoazepinas substituídas como moduladores de receptor toll-like
JP6093759B2 (ja) 2011-06-01 2017-03-08 ジャナス バイオセラピューティクス,インク. 新規の免疫系調節剤
EP2713737B1 (en) 2011-06-01 2016-04-20 Janus Biotherapeutics, Inc. Novel immune system modulators
EA031618B1 (ru) 2011-06-09 2019-01-31 Ризен Фармасьютикалз Са Соединения-модуляторы gpr-119
EA023045B1 (ru) 2011-07-15 2016-04-29 Янссен Фармасьютикалз, Инк. Новые замещенные производные индола в качестве модуляторов гамма-секретазы
DE102011111400A1 (de) * 2011-08-23 2013-02-28 Merck Patent Gmbh Bicyclische heteroaromatische Verbindungen
US9873694B2 (en) 2011-10-04 2018-01-23 Janus Biotherapeutics, Inc. Imidazole quinoline-based immune system modulators
MY178053A (en) 2012-05-18 2020-09-30 Sumitomo Dainippon Pharma Co Ltd Carboxylic acid compounds
JO3407B1 (ar) * 2012-05-31 2019-10-20 Eisai R&D Man Co Ltd مركبات رباعي هيدرو بيرازولو بيريميدين
EP2738172A1 (en) 2012-11-28 2014-06-04 Almirall, S.A. New bicyclic compounds as crac channel modulators
MD4635C1 (ro) 2013-10-14 2020-01-31 Eisai R&D Management Co., Ltd. Compuşi de chinolină substituiţi selectiv
WO2015088045A1 (en) 2013-12-13 2015-06-18 Takeda Pharmaceutical Company Limited Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors
SI3190113T1 (sl) 2014-08-15 2021-09-30 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pirolopirimidinske spojine, ki se uporabljajo kot agonist TLR7
US20170275287A1 (en) 2014-08-22 2017-09-28 Janus Biotherapeutics, Inc. Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
US10071079B2 (en) 2016-06-29 2018-09-11 Bristol-Myers Squibb Company [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
CA3031675A1 (en) 2016-07-30 2018-02-08 Bristol-Myers Squibb Company Dimethoxyphenyl substituted indole compounds as tlr7, tlr8 or tlr9 inhibitors
WO2018049089A1 (en) 2016-09-09 2018-03-15 Bristol-Myers Squibb Company Pyridyl substituted indole compounds
AU2018390820A1 (en) * 2017-12-19 2020-08-06 Bristol-Myers Squibb Company Substituted indole compounds useful as TLR inhibitors

Similar Documents

Publication Publication Date Title
JP2021507912A5 (enExample)
JP2021506941A5 (enExample)
JP2021506858A5 (enExample)
CN115925705B (zh) 杂芳类衍生物调节剂、其制备方法和应用
KR102849449B1 (ko) 치환된 인돌 화합물
KR102742181B1 (ko) 6-아자인돌 화합물
AU2023201522B2 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
EP2516433B1 (en) Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors
EP2451813B1 (en) Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
AU2019286162B2 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
CN117651700A (zh) 2-氨基苯并噻唑化合物及使用方法
JP2020529436A5 (enExample)
JP2021506923A5 (enExample)
CA3085937A1 (en) Diazaindole compounds
KR20190022735A (ko) [1,2,4]트리아졸로[1,5-a]피리디닐 치환된 인돌 화합물
AU2018201903A1 (en) SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS
EA036592B1 (ru) Замещенные трициклические соединения как ингибиторы fgfr
WO2023041049A1 (zh) 作为sos1抑制剂的杂环化合物及其用途
WO2024193683A1 (en) Bicyclic derivatives, compositions and uses thereof
KR20220075381A (ko) 치환된 비시클릭 헤테로아릴 화합물
CA2714352A1 (en) Dual pharmacophores-pde4-muscarinic antagonistics
CN119654322A (zh) Tyk2抑制剂
WO2024146502A1 (en) Wee1 degrading compounds
CN121100113A (zh) 取代的喹喔啉
AU2009212409A1 (en) Dual Pharmacophores- PDE4-muscarinic antagonistics